Spectral AI (MDAI) EBT Growth (1y) (2022 - 2026)
Spectral AI (MDAI) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 17.94% |
| 10 | Spectral AI | 50.53 Mn | 36.53 Mn | 1.11 Mn | 49.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.84% |
| Mar 31, 2026 | -215.30% |
| Dec 31, 2025 | 125.20% |
| Sep 30, 2025 | -141.99% |
| Jun 30, 2025 | -185.76% |
| Mar 31, 2025 | 193.25% |
| Dec 31, 2024 | -113.04% |
| Sep 30, 2024 | 86.27% |
| Jun 30, 2024 | 7.76% |
| Mar 31, 2024 | 10.67% |
| Dec 31, 2023 | -106.90% |
| Sep 30, 2023 | -3,521.36% |
| Jun 30, 2023 | -303.97% |
| Mar 31, 2023 | -150.51% |
| Dec 31, 2022 | 63.28% |
| Sep 30, 2022 | -113.25% |
| Jun 30, 2022 | 151.18% |
| Mar 31, 2022 | 118.95% |